Clinical Trial Material Manufacturing for Global Submissions

A biotechnology company required end-to-end support for its Investigational Medicinal Product (IMP) intended for pivotal Phase III trials in Europe while being manufactured in a third country. We executed a comprehensive EU QP GMP audit of the overseas site, verifying compliance with EU and international standards. Following trial completion, we provided strategic consultancy for the U.S. FDA Biologics License Application (BLA), leveraging robust European clinical data to streamline regulatory approval pathways.